Olathe-based Metactive lands $1.5M, two medical patents
March 21, 2017 | Meghan LeVota
Olathe-based medical device company Metactive released a pair of positive announcements for the firm.
Dr. Nick Franano
In addition to being awarded two patents, the firm closed on a $1.5 million Series A funding round — bringing its total raised to over $9 million. The round was co-led by the Mid-America Angels and an unnamed investor. Previously, the firm has engaged in partnerships with the Kansas Bioscience Authority and the National Institutes of Health.
Metactive Medical focuses on the creation of embolization devices that fights cancer. It’s latest, the Blockstent Microcatheter for embolization of peripheral arteries and veins and the Ballstent Microcatheter for embolization of cerebral aneurysms, are now patented.
CEO Nick Franano said that the issuance of these patents gives Metactive exclusive rights in the U.S. and international market. He added that the capital will help accelerate the firm.
“This new funding provides Metactive with the resources to continue the development and testing of its novel embolization devices,” Franano said in a release. “Our preclinical study results show that both devices routinely provide immediate, complete, and durable occlusion, something that market leading coils, flow diverting stents, and mesh vascular plugs can’t deliver. We look forward to a time when standing in the interventional suite wearing heavy lead protective garments, placing multiple devices, and performing serial angiography waiting for a vessel to occlude will no longer be required to complete an embolization procedure.”
Embolization is a treatment that blocks the flow of blood in specific segments of arteries and veins, enabling doctors to divert blood away from cancerous tumors and other abnormal tissues. More than 150,000 peripheral vascular embolization procedures are performed each year around the world using coils and vascular plugs, which can be difficult to use and often result in incomplete treatment.
Franano is also the CEO of Flow Forward Medical, which recently raised $1 million for its vascular health device.
2017 Startups to Watch
stats here
Related Posts on Startland News
Founder of defunct Symptomly shares lessons from failure
Failure is a touchy subject. But for Derek Bereit — the former CEO and co-founder of mobile asthma tracking company Symptomly — his company’s failure was an opportunity shrouded in a difficult situation. Rather than sulking, Bereit sat down with Startland News to discuss Symptomly’s demise, the lessons it provided him and the possibilities that…
Founders discuss tough decisions entrepreneurs face
Two founders took the stage at Kansas City’s chapter of 1 Million Cups to discuss the vast variety of tough decisions entrepreneurs face when starting and running a business. Stuart Ludlow, co-founder of RFP 365 and Sarah Shipley, co-founder of BikeWalkKC, offered insights and advice for those launching a business. Read about RFP365’s recent funding…
Lenexa studio joins national coworking relief effort for Nepal
Despite the nearly 8,000 miles between them, a Kansas City-area coworking studio is helping with relief efforts in Nepal after a 7.8 magnitude earthquake destroyed hundreds of buildings and claimed thousands of lives. Lenexa-based Plexpod has joined the international “Coworking for Nepal” movement that has attracted dozens of studios to encourage fundraising for Nepal relief…
KC’s first innovation officer reflects on work, city’s tech future
After more than two years of service, Ashley Hand is leaving the driver’s seat of Kansas City’s innovation efforts. Hand, who soon will be departing as Kansas City’s chief innovation officer, was tasked with implementing innovative strategies to improve how city government can better serve Kansas Citians. The city will be accepting applications for the…